Invited Talk RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- NCLB and IDEA- Implications for preparation and certification/licensure of special education teachers
- Neglected once again: Vivax malaria transmission-blocking vaccines
- Neisseria sicca Endocarditis Following Open-Heart Surgery: a Case Report and Review
- Network analysis distinguishes short and prolonged functional changes caused by potent ‘bath salt’ drug MDPV.
- Neuroadaptations underlying nicotine dependence.
- Neurobehavioral Deficits in Addicts: Implications for Life and Recovery
- Neurobehavioral dysfunction in early abstinence and the recovery process
- Neurobehavioral dysregulation: Are there implications for long-term behavioral change?
- Neurobehavioral Systems Underlying Alcohol-Related Emotional and Cognitive Dysregulation
- Neurobiology of Disease - short course; 4 lectures
- Neurocognitive Compromise with Substance Misuse
- Neurocognitive Consequences: The Bigger Picture
- Neurodevelopmental Disruptive Behavior: What Do We Know and When Did We Know It
- Neuroimaging and Cognitive Performance in Older Adults
- Neurotransmitter Alterations in the Aging Brain
- New Antibiotics – Old Diseases
- New approach to quantifying remediation
- New Diagnostic & Therapeutic Modalities: GI Bleeding
- New funding mechanisms in livestock research
- New Imaging Techniques for Intestinal Fibrosis
- New Insights into the Management of HCV
- New Insights into the Management of HCV
- New insights into the molecular and physiological facets of inclusion formation in alpha-synucleinopathies
- New Therapies in Hepatitis C
- New Treatment Paradigms for Chronic Hepatitis C Infection
- New Treatments of HCV
- New treatments on Chronic Hepatitis B
- New Updates in Hepatitis C
- Nicotine and Drugs: What Drives the Affair?
- NIH advanced Radiation Therapeutics